Abstract
This study has two purposes: — to know whether the European standard series is still the key reference when it comes to contact dermatitis, i.e., are its components still the most frequently involved allergens in contact dermatitis nowadays? — to assess the results of the European standard series among French and Belgian dermatologists/allergists as, so far, most of them have failed to provide statistical data within the European community of allergists/dermatologists. 18 participants from 2 dermatology and allergy centres in Belgium and 11 centres in France collected their results from 3,073 patients tested in 2011. They assessed the relevance of some tests as well as that of the standard series and additional series to establish an etiological diagnosis of contact dermatitis. These results, together with the history of the European standard series, have shownthat some allergens are obsolete and that others should be included in a new standard series for which we are making a few suggestions.
Similar content being viewed by others
References
Lachapelle JM. The standard series of patch tests. In: Patch testing and prick testing, 2nd Ed, 1 Vo.l Springer Berlin 2009, pp 71–82.
Cheng LS, Alikhan A, Maibach HI. Compilation of international standards for patch testing methodology and allergens. Dermatitis 2009; 20: 257–260.
Raison-Peyron N. Méthodologie des patch tests: supports et allergènes. Ann Dermatol Venereol 2009; 136: 585–591.
Dooms Goossens A. Evaluation critique du test épicutané. In: Progrès en Dermato-Allergologie tome II. Médiscript Ed. Viternes 1996: 103–107.
Wahlberg JE. Patch-testing. In Contact Dermatitis [textbook of], Rycroft R J G, Menné T, Frosch P J, Benezra C Eds, Berlin 1991, Springer Verlag, 239–268.
Ada S, Seckin D. Patch testing in allergic contact dermatitis: is it useful to perform the cosmetic series in addition to the European standard series? J Eur Acad Dermatol Venereol 2010; 24: 1192–1196.
Akasya-Hillenbrand E, Ozkaya-Bayazit E. Patch test results in 542 patients with suspected contact dermatitis in Turkey. Contact Dermatitis 2002; 46: 17–23.
Isaksson M, Brandao FM, Bruze M, Goossens A. Recommendation to include budesonide and tixocortol pivalate in the European standard series. Contact Dermatitis 2000; 43: 41–42.
Bruze M, Goossens A. Gruvberger B; ESCD; EECDRG. Recommendation to include methyldibromo glutaronitrile in the European standard patch test series. Contact Dermatitis 2005; 52: 24–28.
Frosch PJ, Rastogi SC, Pirker C, et al. Patch testing with a new fragrance mix — reactivity to the individual constituents and chemical detection in relevant cosmetic products. Contact Dermatitis 2005; 52: 216–225.
Bruze M, Andersen KE. Goossens A; ESCD; EECDRG. Recommendation to include fragrance mix 2 and hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral) in the European baseline patch test series. Contact Dermatitis 2008; 58: 129–133.
Frosch PJ, Johansen JD, Menné T, et al. Lyral is an important sensitizer in patients sensitive to fragrances. Br J Dermatol 1999; 141: 1076–1083.
Giordano-Labadie F. Listes d’éviction. Ann Derrm Venereol 2009; 136: 656–658.
Lachapelle JM, Ale SI, Freeman S, et al. Proposal for a revised international standard series of patch tests. Contact Dermatitis 1997; 36: 121.
Cleenewerck M-B. Patch-testing methods: Méthodologie des patch-tests: Batteries dites spécialisées, additionnelles. Ann Derm Venereol 2009; 136: 593–595.
Castelain M. Effets secondaires, complications et contreindications des patch-tests. Ann Derm Venereol 2009; 136: 645–649.
Vigan M, Adessi B, Arnoult E, et al. Tests épicutanés chez l’enfant: élaboration d’une batterie standard adaptée. Ann Derm Venereol 2000; 127(suppl. 4): 116–117.
Vigan M. Particularités des tests épicutanés chez l’enfant. Ann Derm Venereol 2009; 136: 617–620.
De Waard-van der Spek FB, Oranje AP. Patch tests in children with suspected allergic contact dermatitis: a prospective study and review of the literature. Dermatology 2009; 218: 119–125.
The European Surveillance System of Contact Allergies [ESSCA]: results of patch testing the standard series, 2004. J Eur Acad Dermatol Venereol 2008; 22:174–181.
Machovcova A, Dastychova E, Kostalova D, et al. Common contact sensitizers in the Czech Republic. Patch test results in 12,058 patients with suspected contact dermatitis. Contact Dermatitis 2005; 53: 162–166.
Uter W, Rämsch C, Aberer W, et al. The European baseline series in 10 European Countries, 2005/2006-results of the European Surveillance System on Contact Allergies [ESSCA]. Contact Dermatitis 2009; 61: 31–38.
Uter W, Hegewald J, Aberer W, et al. The European standard series in 9 European countries, 2002/2003 — first results of the European Surveillance System on Contact Allergies. Contact Dermatitis 2005; 53: 136–145.
Fairhurst DA, Shah M. Comparison of patch test results among white Europeans and patients from the Indian subcontinent living within the same community. J Eur Acad Dermatol Venereol 2008; 22: 1227–1231.
El-Rab MO, al-Sheikh OA. Is the European standard series suitable for patch testing in Riyadh, Saudi Arabia? Contact Dermatitis 1995; 33: 310–314.
Greig JE, Carson CF, Stuckey MS, et al. Prevalence of delayed hypersensitivity to the European standard series in a self-selected population. Australas J Dermatol 2000; 41: 86–89.
Sharma VK, Chakrabarti A. Common contact sensitizers in Chandigarh, India. A study of 200 patients with the European standard series. Contact Dermatitis 1998; 38: 127–131.
Lam WS, Chan LY, Ho SC, et al. A retrospective study of 2585 patients patch tested with the European standard series in Hong Kong (1995-99). Int J Dermatol 2008; 47: 128–133.
Akyol A, Boyvat A, Peksari Y, et al. Contact sensitivity to standard series allergens in 1038 patients with contact dermatitis in Turkey. Contact Dermatitis 2005; 52: 333–337.
Lazarov A. European Standard Series patch test results from a contact dermatitis clinic in Israel during the 7-year period from 1998 to 2004. Contact Dermatitis 2006; 55: 73–76.
Li LF, Guo J, Wang J. Environmental contact factors in eczema and the results of patch testing Chinese patients with a modified European standard series of allergens. Contact Dermatitis 2004; 51: 22–25.
Landeck L, Schalock PC, Baden LA, et al. Patch-testing with the standard series at the Massachusetts General Hospital, 1998 to 2006. Dermatitis 2009; 20: 89–94.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Castelain, M., Assier, H., Baeck, M. et al. The European Standard Series and its additions: are they of any use in 2013?. Eur J Dermatol 24, 15–22 (2014). https://doi.org/10.1684/ejd.2013.2258
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2013.2258